US Stock MarketDetailed Quotes
INCY Incyte
- 69.805
- -7.165-9.31%
Trading Nov 19 15:41 ET
13.45BMarket Cap775.61P/E (TTM)
74.100High65.020Low9.02MVolume66.910Open76.970Pre Close619.19MTurnover5.62%Turnover Ratio26.34P/E (Static)192.65MShares83.95052wk High4.24P/B11.20BFloat Cap50.35052wk Low--Dividend TTM160.50MShs Float153.150Historical High--Div YieldTTM11.80%Amplitude1.850Historical Low68.641Avg Price1Lot Size
About Incyte Company
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Company Profile
SymbolINCY
Company NameIncyte
Listing DateNov 4, 1993
Issue Price7.50
Founded1991
CEOMr. Herve Hoppenot
MarketNASDAQ
Employees2524
Fiscal Year Ends12-31
Address1801 Augustine Cut-Off
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19803
Phone1-302-498-6700
Websitehttp://www.incyte.com
Company Executives
- Name
- Position
- Salary
- Herve Hoppenot
- Chairman of the Board, President and Chief Executive Officer
- 16.66M
- Thomas Tray
- Vice President and Chief Accounting Officer
- --
- Dr. Steven H. Stein, M.D.
- Executive Vice President and Chief Medical Officer
- 5.63M
- Christiana Stamoulis, M.B.A.
- Executive Vice President and Chief Financial Officer
- 5.08M
- Jonathan Elliott Dickinson
- Executive Vice President and General Manager, Europe
- --
- Barry P. Flannelly, Pharm.D.
- Executive Vice President and General Manager, North America
- 4.09M
- Paula J. Swain
- Executive Vice President, Human Resources
- --
- Sheila A Denton
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Michael James Morrissey
- Executive Vice President and Head of Global Technical Operations
- --
- Vijay K. Iyengar
- Executive Vice President, Global Strategy and Corporate Development
- --
- Dr. Pablo J. Cagnoni, M.D.
- President and Head of Research and Development
- 15.83M
- Paul J. Clancy
- Independent Director
- 479.76K
- Julian C. Baker
- Lead Independent Director
- 512.76K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 454.76K
- Jean-Jacques Bienaime
- Independent Director
- 478.76K
- Dr. Jacqualyn A. Fouse, PhD
- Independent Director
- 466.26K
- Dr. Edmund P. Harrigan, M.D.
- Independent Director
- 482.26K
- Dr. Katherine A. High, M.D.
- Independent Director
- 454.76K
- Dr. Susanne Schaffert, PhD
- Independent Director
- 444.76K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
